Norman Ruchholtz
Chief Executive Officer at Cantourage GmbH
Norman Ruchholtz active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cantourage GmbH
 Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Chief Executive Officer | 31/12/2018 | - |
| Founder | 31/12/2018 | - |
Career history of Norman Ruchholtz
Former positions of Norman Ruchholtz
| Companies | Position | Start | End |
|---|---|---|---|
| CANTOURAGE GROUP SE | Founder | 31/12/2018 | - |
Statistics
International
| Germany | 3 |
Operational
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CANTOURAGE GROUP SE | Process Industries |
| Private companies | 1 |
|---|---|
Cantourage GmbH
Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Norman Ruchholtz
- Experience
